Seven Stocks Moving on Heavy Volume

Published Nov 18, 2026, 3:48 PM

By Ben Hansel, Senior Financial Editor 247MarketNews

DENVER, Colo. (247MarketNews) — SaverOne 2014 (NASDAQ:SVRE), Cue Biopharma (NASDAQ:CUE), Highway Holdings (NASDAQ:HIHO), Mega Matrix (NYSEAMERICAN:MPU), Chanson International (NASDAQ:CHSN), Akanda (NASDAQ:AKAN) and ClearOne (NASDAQ:CLRO) are all seeing heightened trading activity.

SaverOne 2014 (NASDAQ:SVRE) — Software expansion meets extreme momentum

SaverOne is attracting extraordinary speculative attention, with trading activity reaching hundreds of times its normal volume in early-morning market data. The most relevant fundamental development is its October 26 announcement of a new software-only driver-safety product. Unlike its earlier hardware-dependent approach, the new offering is designed to work through existing vehicle telematics and infotainment platforms. The company says integrations include Geotab and Ituran, with the product available on the Geotab Marketplace. It also reports integration with a major commercial vehicle manufacturer's infotainment system.

Cue Biopharma (NASDAQ:CUE) — Clinical progress meets an extraordinary rebound

Cue Biopharma's recovery attempt follows a brutal trading session. Shares plunged approximately 80% on November 17, closing at $2.83 after trading as high as $13.52. The subsequent rebound is therefore better understood as a potential oversold recovery than proof that the market has fully embraced the company's latest clinical update. The November 16 earnings announcement did contain meaningful developments: CUE-221 demonstrated positive Phase 2 results in chronic spontaneous urticaria, while CUE-401 entered human clinical development with first-in-human dosing.

The clinical numbers offer a reason to keep watching. In a high-baseline-IgE subgroup, 78% of patients receiving the 4 mg/kg CUE-221 dose achieved complete hive resolution at week 12, compared with zero in the placebo group, according to the company.

Highway Holdings (NASDAQ:HIHO) — Manufacturing turnaround gets attention

Highway Holdings has one of the clearest fundamental catalysts in this group. Its November 18 fiscal second-quarter report showed revenue climbing 107% year over year to $2.44 million, gross profit increasing 201% to $907,000, and gross margin expanding to 37.2% from 25.5%. Operating income reached $54,000, compared with an operating loss of $542,000 in the year-earlier quarter. The company also reported a return to net profitability, although net income was only $10,000.

The results arrive amid a broader restructuring. David Lazar completed a $7 million strategic investment on November 4 and became CEO. The transaction contemplates a spin-off of the legacy manufacturing operation and a $2 million aggregate cash dividend for eligible shareholders.

Mega Matrix (NYSEAMERICAN:MPU) — Dramatic move without new announcement

Mega Matrix also entered the speculative spotlight, with strong volume, especially against the company's reported share structure, following its September 15 one-for-20 share consolidation, and the much smaller volumes seen in recent sessions.

Chanson International (NASDAQ:CHSN) — Low-float bakery stock speculative bid

Chanson International's move is particularly interesting because its underlying financial results have improved even though revenue has not. In its September 18 first-half fiscal 2026 report, the Chinese bakery operator reported $8.3 million in revenue, down 4.5%, but returned to profitability with $800,000 in net income compared with a $1 million loss a year earlier.

Akanda (NASDAQ:AKAN) — Heavy trading despite potential dilution ove

Akanda's latest rally is another example of a stock attracting speculative capital without an obvious new operating announcement. Its November 18 trading activity has been substantial, but the more important recent corporate development is a November 6 amended registration statement outlining a proposed $10 million preferred-share offering. The preliminary prospectus covers 10,000 Series A convertible voting preferred shares, each with a $1,000 stated value, and up to 11,312,217 common shares issuable upon conversion, using an assumed $0.884 conversion price.

ClearOne (NASDAQ:CLRO) — $4M financing may change company's survival prospects

ClearOne's rally has a substantial corporate-finance catalyst behind it. A November 17 SEC filing disclosed that the company completed transactions involving approximately $4 million in total consideration. This included $2.76 million in gross cash proceeds from private placements and the conversion of approximately $1.24 million in debt into common shares. The transactions involved the issuance of 999,999 shares at a deemed $4.00 per-share price, leaving 3,675,411 shares outstanding. First Finance alone purchased 188,885 shares for $755,540 in cash and received another 311,114 shares through debt conversion. This was a private placement, not an ordinary open-market insider purchase.

About the Author

Ben Hansel is a financial and business writer with a background in business, sales, and finance. He graduated from the University of Texas at El Paso. His professional and educational background informs his coverage of financial markets, corporate developments, economic trends and the broader forces shaping the market.

Important Editorial Note: 247MarketNews highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication.  Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.